Tracking the Body's hidden response to cancer immunotherapy
NCT ID NCT06823401
Summary
This study aims to understand how lung cancer patients' immune systems respond to immunotherapy drugs. Researchers will track whether patients develop antibodies against their immunotherapy medications and whether these antibodies affect treatment effectiveness or side effects. The study involves collecting blood samples from 270 patients before and during their standard immunotherapy treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Tumori Regina Elena
ENROLLING_BY_INVITATIONRoma, RM, 000144, Italy
-
Istituto Tumori Regina Elena
RECRUITINGRoma, RM, 00128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.